3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?

Thyroid hormones, their metabolites, and synthetic analogues are potential anti-steatotic drug candidates considering that subclinical and manifest hypothyroidism is associated with hepatic lipid accumulation, non-alcoholic fatty liver disease, and its pandemic sequelae. Thyromimetically active comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sane, Rajas, Wirth, Eva K., Köhrle, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322486/
https://www.ncbi.nlm.nih.gov/pubmed/35888706
http://dx.doi.org/10.3390/metabo12070582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322486/
https://www.ncbi.nlm.nih.gov/pubmed/35888706
http://dx.doi.org/10.3390/metabo12070582

Ejemplares similares